GlassScriptPhysician profile
Srinivas Vallapuri
NPI 1992704209
$13,406.62
in general payments reported to CMS, 2019-2025
19 companies · $2,346 in 2025
The $2,346 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,068 · 2020: $1,177 · 2021: $1,068 · 2022: $2,509 · 2023: $2,665 · 2024: $573 · 2025: $2,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,358 · Travel and Lodging: $2,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,358.07 |
| Travel and Lodging | $2,225.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $6,322.12 | 2019-2025 | Sapien 3 Ultra Resilia, Evoque, Pascal |
| Abbott Laboratories | $2,610.70 | 2019-2024 | Amplatzer Amulet, Mitraclip, Diamondback Coronary |
| Boston Scientific Corporation | $1,710.95 | 2019-2025 | Avvigo Guidance System, General - Therapies, Rotapro |
| Philips North America LLC | $446.42 | 2021-2023 | |
| Abiomed | $412.67 | 2020-2025 | |
| Cardiovascular Systems INC. | $259.48 | 2019-2021 | |
| Shockwave Medical, INC | $255.80 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $232.56 | 2021-2022 | |
| Thrombolex, INC. | $212.14 | 2025 | Bashir Endovascular Catheter |
| Canon Medical Systems USA, INC. | $193.92 | 2025 | Interventional Angiography System |
| Medtronic Vascular, INC. | $152.71 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $151.81 | 2019-2022 | |
| Esperion Therapeutics, INC. | $121.26 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.33 | 2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $76.85 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ekos Corporation | $53.42 | 2019 | |
| Pfizer INC. | $34.02 | 2024-2025 | |
| Medtronic, INC. | $32.41 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $20.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinivas Vallapuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.